• Produktbild: Sino-African Cooperation for Schistosomiasis Control in Zanzibar
  • Produktbild: Sino-African Cooperation for Schistosomiasis Control in Zanzibar
Band 15

Sino-African Cooperation for Schistosomiasis Control in Zanzibar A Blueprint for Combating other Parasitic Diseases

Fr. 171.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.07.2022

Abbildungen

X, 293 p. 92 illus., 88 illus. in color.

Herausgeber

Kun Yang + weitere

Verlag

Springer

Seitenzahl

293

Maße (L/B/H)

23.5/15.5/1.7 cm

Gewicht

464 g

Auflage

1st ed. 2021

Sprache

Englisch

ISBN

978-3-030-72167-1

Beschreibung

Portrait


Professor Heinz Mehlhorn 
studied at the Rheinische Friedrich-Wilhelms University of Bonn (Germany). He was chairman of the parasitological institutes in Düsseldorf and Bochum. As a former president of the World Society of Protozoology and long-standing member of the steering committee of the World Society of Parasitologists he runs ongoing lectures in parasitology in several countries and teaches courses for medical students in Düsseldorf. He has published a variety of specialist books on parasitological problems in German, French, English and Spanish. He holds the patents on 12 antiparasitic drugs, which are the basis of products sold by the university spin-off company Alpha-Biocare GmbH (Neuss, Germany), which produces medications, repellents and wound care products for humans and animals.





Kun Yang
is Professor of schistosomiasis control and global health at the Jiangsu Institute of Parasitic Diseases in China. He is secretary general of the Jiangsu Provincial Endemic Diseases Association, and president of the professional committee of schistosomiasis. He has published over 100 peer reviewed original research articles and a variety of specialist books on schistosomiasis control and elimination in China. He has received national and international awards for his work.




Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.07.2022

Abbildungen

X, 293 p. 92 illus., 88 illus. in color.

Herausgeber

Verlag

Springer

Seitenzahl

293

Maße (L/B/H)

23.5/15.5/1.7 cm

Gewicht

464 g

Auflage

1st ed. 2021

Sprache

Englisch

ISBN

978-3-030-72167-1

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Sino-African Cooperation for Schistosomiasis Control in Zanzibar
  • Produktbild: Sino-African Cooperation for Schistosomiasis Control in Zanzibar
  • Chapter 1. Schistosoma haematobium (Bladder fluke): Life cycle and morphology.- Chapter 2. Praziquantel- a broad spectrum drug acting against trematodes and cestodes parasitizing humans and animals.- Chapter 3. The Global Status and Control of Human Schistosomiasis: An Overview.- Chapter 4. Schistosomiasis control program in Zanzibar: an overview.- Chapter 5. Sino-Africa cooperation project of schistosomiasis control: a pathway analysis.- Chapter 6. China-Zanzibar cooperation project of schistosomiasis control: study design.- Chapter 7. Epidemiological survey of schistosomiasis in Zanzibar.- Chapter 8. Mapping of schistosomiasis haematobia in Zanzibar.- Chapter 9. Bulinus snails control by China-made niclosamide in Zanzibar: experiences and lessons.- Chapter 10. Human chemotherapy by China-made praziquantel in Zanzibar: efficacy and safety .- Chapter 11. A package of health education materials: effectiveness for schistosomiasis control in Zanzibar.- Chapter 12. The novel strategy of China-Zanzibar cooperation project of Schistosomiasis control: the integrated strategy.- Chapter 13. Construction of an Epidemic Management Information System leading to schistosomiasis elimination in Zanzibar.- Chapter 14. Management of China-Zanzibar cooperation project: lessons learned.- Chapter 15. Evaluation of China-Zanzibar cooperation project of Schistosomiasis: no-stakeholder.